🇺🇸
United States · US · US:0002-1717_1ece6e73-2242-434e-b297-7ccf07a54c1e
Inluriyo
Orange BookUNIISPL
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerEli Lilly and Company
CountryUS (United States)
ATC code—
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 3
- ndc11000217172828 TABLET, FILM COATED in 1 BOTTLE (0002-1717-28)
- ndc11000217175656 TABLET, FILM COATED in 1 BOTTLE (0002-1717-56)
- ndc11000217176156 TABLET, FILM COATED in 1 BOTTLE (0002-1717-61)
Annotations
UNII (FDA Substance ID)
9CXQ3PF69U
IMLUNESTRANT
Orange Book
N218881
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "9CXQ3PF69U",
"rxcui": null,
"inchikey": "UVBQMXOKKDCBJN-MUUNZHRXSA-N",
"display_name": "IMLUNESTRANT",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"5bc172e4-e8a2-441a-be52-279a7f890196": {
"match": "brand_token",
"title": "INLURIYO (IMLUNESTRANT) TABLET, FILM COATED [ELI LILLY AND COMPANY]",
"spl_version": "6",
"published_date": "2026-02-25"
}
},
"productid": "0002-1717_1ece6e73-2242-434e-b297-7ccf07a54c1e",
"productndc": "0002-1717",
"dosage_form": "TABLET, FILM COATED",
"orange_book": {
"appl_no": "218881",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "EQ 200MG BASE",
"product_no": "001",
"approval_date": "Sep 25, 2025"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "IMLUNESTRANT",
"proprietary_name": "Inluriyo",
"active_ingred_unit": "mg/1",
"application_number": "NDA218881",
"marketing_category": "NDA",
"nonproprietary_name": "imlunestrant",
"start_marketing_date": "20250925",
"active_numerator_strength": "200"
}Access this data programmatically
Query Inluriyo and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.